To transmit inhibitory signals to the T-cell receptor (TCR) pathway, PD-1 binds to PD-L1 on the surface of tumor cells and/or tumor-associated macrophages (TAMs) in the tumor microenvironment [43,44]. Here, CD274 is linked to neoplasm.